
Moratorium on 45-hour work week for nurses extended
PUTRAJAYA: The interim moratorium on the implementation of a 45-hour work week for nurses has been extended by another month, Health Minister Datuk Seri Dr Dzulkefly Ahmad said today.
He said the extension was to enable the ministry to examine and understand various aspects of healthcare workers, especially welfare issues, before recommendations are presented to the Cabinet on July 1.
'The process is now in its final stage, and engagements have been held several times. But as I said before, I will not decide without a thorough understanding of the nursing programme and related matters.
'Going from here, it is for me to conclude, but what is important is to consider all factors so that whatever decision is made will be truly fair,' he told a press conference after attending the national-level Midwife Day and Nurses Day 2025 celebration, here.
Dzulkefly has been reported to have said that the Public Service Department had approved an interim period of three months, from Dec 1, 2024, to Feb 28, 2025, to prepare for the implementation of a 45-hour work week at the Ministry of Health.
On Nov 21 last year, Dzulkefly said that the change in shift work hours for nurses was appropriate, subject to the Public Service Remuneration System that was implemented on Dec 1, 2024.
He said the 45-hour work week set through the system was essentially reduced by one hour compared to 46 hours a week as provided under the General Orders.
Asked about the issue of nurses' allowances that had been raised by the Malayan Nurses Union (MNU), he said the matter was still under discussion at the ministry level.
'I have directed that this matter be examined, and it will take some time because it is still at the discussion stage,' he said.
On March 9, the MNU sought a government review of all nurses' allowances, including the RM1,000 per month regional allowance for those serving outside their home state.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Express
2 hours ago
- Daily Express
Callabio, Sanomedical to start operations at SAIP
Published on: Tuesday, June 03, 2025 Published on: Tue, Jun 03, 2025 Text Size: KOTA KINABALU: Callabio Manufacturing and Sanomedical Asiapac will begin operations at the Sabah Agro-Industrial Park (SAIP) on 1 June 2025. Callabio will run the Herb Processing and Product Line facilities to produce nutraceuticals, pharmaceuticals, herbal-based medicines, and drinks. Sanomedical will operate the Cosmetic Lab to manufacture medical products. The move is expected to boost local industry, create jobs, and support the Sabah Maju Jaya agenda. Both firms signed lease agreements with SAIP, each placing deposits of RM125,000 and RM100,000 respectively. The signing was witnessed by Sabah Industry Development and Entrepreneurship Minister Datuk Phoong Jin Zhe. During the event, CAIQ Biosecurity proposed a joint venture to turn SAIP into a hub for testing and registering Sabah products for export to China. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia


Borneo Post
3 hours ago
- Borneo Post
Sabah Agro-Industrial Park takes off: Two lease deals signed
(Standing from left): Annef Osyairi, general manager of SAIP; Dr Mohd Yaakub Johari; Dr Ch'ng Soo Ep (CAIQ Test Malaysia); Datuk Phoong Jin Zhe; Datuk Ar. James Wong Kein Peng; Datuk Ts Dr Ramzah Dambul; and Dr Ir Chong Vun Leong (far right). KOTA KINABALU (June 3): SAIP Sdn Bhd has taken a major step towards the commercialisation of the Sabah Agro-Industrial Park (SAIP) by signing two lease agreements. Three key facilities namely the Herbal Processing Facility (HPF), Product Launch Facility (PLF) and Cosmetic Laboratory, are set to commence operations on June 1, 2025. HPF and PLF will be leased to Callabio Manufacturing Sdn Bhd, which will produce nutraceuticals, pharmaceuticals, herbal-based food and medicine, and isotonic beverages in Sabah. Meanwhile, the Cosmetic Laboratory will be leased to Sanomedical Asiapac Sdn Bhd, which will operate as a medical product manufacturer in the state. With the involvement of these two companies in Sabah's manufacturing and production sector, SAIP is expected to stimulate the local market and serve as a catalyst for encouraging participation from local entrepreneurs in producing fully certified finished products. Additionally, the arrival of these companies is anticipated to create more job opportunities in Sabah in line with the Sabah Maju Jaya (SMJ) development agenda. The agreements were signed by SAIP Sdn Bhd directors Datuk Ar. James Wong and Datuk Dr Ts Ramzah Dambul. Callabio Manufacturing Sdn Bhd was represented by its Chief Executive Officer, Dr Shahir Suhaimi, while Sanomedical Asiapac Sdn Bhd was represented by its general manager, Helgah Veronica Smith Lagadan. Both companies submitted deposits of RM125,000 and RM100,000 respectively as a commitment to begin operations at SAIP. The signing ceremony was witnessed by the Minister of Industrial Development and Entrepreneurship and chairman of SAIP Sdn Bhd, Datuk Phoong Jin Zhe. He expressed his satisfaction with the progress and congratulated SAIP's management on the achievement. During the event, CAIQ Biosecurity Sdn Bhd also presented a business proposal to establish a joint venture with SAIP, aimed at positioning the industrial park as a major centre for testing, inspection and registration of food, supplement, agriculture and aquaculture products from Sabah for export to China.


The Star
10 hours ago
- The Star
Govt must ban vapes to avoid burdening public healthcare system, says Segamat MP
JOHOR BARU: Firm action has to be taken by the government to completely ban vape usage, distribution and sale to avoid heavily burdening the public healthcare system, says a Johor lawmaker. Segamat MP R. Yuneswaran highlighted the economic burden on the healthcare system, where the treatment for a single Vaping Product Use-Associated Lung Injury (Evali) patient could cost up to RM150,000. 'Without effective controls, treatment costs for vape-related diseases could rise to RM369mil annually by 2030, nearly matching the government's projected vape tax revenue of RM500mil per year. 'This shows any economic benefit from the vape industry does not justify the healthcare costs,' he said in a statement Tuesday (June 3). He pointed out that several state governments such as Johor, Kedah and Terengganu have stopped renewing business licences for vape sales, effectively banning the product in their jurisdictions. Yuneswaran also criticised the federal government's move in 2023 to exempt vape nicotine liquids from the Poisons Act 1952, which allowed the unregulated sale of vape products. 'This has caused the vape market to grow rapidly, making it even harder to control, especially among youths,' he said. He also lamented the removal of the Generational End Game (GEG) clause from the recently passed Control of Smoking Products for Public Health Act 2023. The clause would have banned the sale of nicotine products to anyone born after 2007. 'That was a missed opportunity because without GEG and comprehensive controls, efforts to curb nicotine addiction among youths will be even more difficult,' he said. On Monday (June 2), the Health Ministry issued a statement saying that e-cigarette liquids can be legally sold in Malaysia, but they are subject to strict regulations aimed at protecting public health. The ministry was reportedly responding to recent media reports about a company that had been granted an interim manufacturing licence to produce e-cigarette devices using nicotine-infused liquids or gels. The ministry said decisions related to the importation, manufacturing and distribution of such liquids are 'collectively made by various government agencies'. It clarified that the issuance of manufacturing licences falls under the purview of the Investment, Trade and Industry Ministry via the Malaysian Investment Development Authority, as provided for under the Industrial Coordination Act.